Introduction
Founders spend decades building something real, then get one shot to sell it right. The valuation method a buyer chooses can swing that number by millions.
Middle-market dealmaking is active but far from smooth. In H1 2023 alone, there were 378 middle-market M&A transactions worth $139.6 billion.
Yet a wide gap persists between what owners believe their businesses are worth and what buyers actually offer, a pattern long noted in AICPA research on private company deal-making.
That gap is why valuation literacy matters. It shapes negotiation leverage, deal structure, and what actually lands in your bank account.
It also helps to know where the number is finally set. Not in a spreadsheet, but in an investment committee meeting, where the first question is not what the business earns today but what it becomes. This article breaks down what M&A valuation is, the three core methods, what the committee is really testing, and which method applies to you.
Key Takeaways
- M&A valuation blends multiple methods, not a single formula
- The three core approaches are asset-based, market-based, and income-based (DCF)
- Buyers and sellers rarely start at the same number; methodology closes that gap
- Industry, growth stage, and data availability determine which method carries the most weight
- The buyer's investment committee prices what the business becomes, not what it earned last year
What Is M&A Valuation?
M&A valuation is the process of assigning an economic worth to a target company's equity or assets, guiding what a buyer pays and what a seller accepts.
Valuation goes beyond spreadsheet math. Advisors and deal teams weigh:
- Lifecycle stage: early growth versus mature, stable operations
- Growth trajectory: historical trends and forward momentum
- Competitive position: market share, differentiation, customer concentration
- Replication cost: what it would take a buyer to build the same capability from scratch
Both sides use that figure as a negotiation tool: a price each can defend to boards, investors, or spouses.
Why Valuation Matters in Middle-Market M&A
Accurate valuation affects everything downstream: deal terms, buyer confidence, financing approval, and the seller's final proceeds.
Buyers and sellers naturally land on different numbers. Sellers price in growth potential and sentimental value. Buyers price in risk, integration cost, and what they'd need to invest post-close. Objective valuation methodology is what bridges that gap.
Without rigorous valuation, deals go sideways. According to ACG's middle-market dealmaking coverage, industry sources reported that a large share of deals launched in 2022 never closed. That signal is anecdotal, not a formal survey finding. Common consequences include undervaluation, lost negotiation leverage, and financing that falls through during diligence.
The Founder-Dependency Problem
Founder-led companies generating $10 million to $100 million in revenue face a specific challenge: institutional buyers view heavy reliance on the founder as risk, not strength.
In one Exit Boston engagement, institutional buyers initially capped a profitable regional manufacturer at no more than 4.8x EBITDA. Profitability was not the issue. Buyers discounted the business because of:
- Insufficient leadership depth beyond the founder
- Founder-centered decision-making and customer relationships
- Weak management incentives
- Limited platform readiness for scaling or integration
Owner independence is the threshold question in these deals, and closing that gap is what moves the multiple most.
The Three Primary M&A Valuation Methods
No single model fits every deal. Appraisers typically triangulate value using two or three methods, then reconcile the results into a defensible range.
Cost/Asset-Based Approach
This method values a business based on the cost to replicate its tangible assets, or net asset value after subtracting liabilities. It focuses on the balance sheet, not earnings or comparables.
- Best suited for: asset-heavy businesses like manufacturing, distribution, and specialty materials companies
- Strengths: straightforward, defensible when assets carry most of the value
- Limitations: undervalues businesses with strong intangible value such as brand equity, customer relationships, IP, and recurring revenue
The American Society of Appraisers cautions that this approach shouldn't be the sole basis for valuing an operating going-concern business unless it's customary among buyers and sellers in that space and the appraiser can justify it, per ASA's Business Valuation Standards.
Market Approach (Comparable Company & Precedent Transaction Analysis)
This benchmarks your business against recently sold similar companies or public peers, using multiples like EV/EBITDA or revenue multiples.
- Best suited for: industries with active deal flow, such as food and beverage, building products, and electronic manufacturing services
- Strengths: grounded in real market pricing, intuitive for buyers
- Limitations: thin data for niche or hybrid businesses; private deal terms are often confidential
Private transaction data does exist. GF Data tracks deals between $10 million and $500 million, drawing on 30+ data points per transaction from over 330 contributor firms, according to GF Data's private M&A transaction database. In H1 2025, manufacturing transactions averaged 5.8x TEV/EBITDA, close to the long-run norm of 5.6x.
Income Approach (Discounted Cash Flow)
DCF projects future free cash flows and discounts them back to present value using a risk-adjusted rate, often a weighted average cost of capital (WACC).
- Best suited for: growth companies with strong, forecastable cash flow trends
- Strengths: captures future earning power, not just historical performance
- Limitations: highly sensitive to growth assumptions, discount rates, and terminal value; unrealistic projections can distort the number
DCF is the primary income-approach method, but the discount rate must match the actual risk profile of the projections being discounted, according to Kroll's business valuation guidance. Optimistic growth assumptions without matching risk adjustments inflate value, and break down under buyer diligence.
In practice, advisors weight each method by data quality and deal context, then reconcile the outputs into a range buyers and sellers can defend.
Key Metrics That Influence the Final Number
EBITDA remains the most common lens buyers use to normalize earnings across companies for comparison. Adjusted EBITDA strips out interest, taxes, depreciation, amortization, and one-time or owner-specific expenses. That includes replacing owner compensation with market-rate pay for the role.
Multiples vary widely depending on the dataset and buyer type:
| Source | Period | Metric | Result |
|---|---|---|---|
| GF Data (PE-sponsored deals) | Q3 2025 | Avg. TTM adjusted EBITDA multiple | 7.5x |
| GF Data (manufacturing) | H1 2025 | Avg. TEV/EBITDA | 5.8x |
| Capstone (broader middle-market) | 2023–2025 | Avg. EV/EBITDA | 9.0x–9.8x |
These figures aren't interchangeable; they cover different deal populations.
Beyond the base multiple, three factors shift the negotiated price:
- Synergy value: cost savings or revenue upside a strategic buyer expects post-close
- Control premiums: extra paid for the ability to direct company decisions
- Buyer type: strategic acquirers and private equity firms often value the same business differently
In one Exit Boston engagement, a label manufacturer sold at 6.4x EBITDA after roughly six months of preparation, having previously been unable to clear 4.8x. The move on to 8.2x, with EBITDA growing from $3.4 million to $9.0 million, took four and a half years and three bolt-on acquisitions under private equity ownership. Both stages came from strengthening the business, not from negotiation tactics.
What the Investment Committee Is Actually Pricing
Whichever method produces the base number, a committee decides whether to act on it. In the client's own account of one such meeting, a managing partner chairs, with a deal lead, an operating partner, a CFO, a risk officer and an associate. The memo is an aerospace machining business with $8 million of EBITDA, entering at 7.2x, founder rolling 20 percent.
The discussion is not about last year. The deal lead describes three acquisition targets averaging roughly $2.5 million of EBITDA each, available at 5 to 5.5x and consolidated into a 7 to 8x platform, producing pro forma EBITDA of $18 to $20 million within five years. The operating partner says the founder is not being underwritten as the long-term operator. The CFO models 2.5x senior debt at close. The associate runs the exit: roughly $19 million of EBITDA at 8.5x, about $160 million of enterprise value, a 4.0x to 4.2x return and a mid-20s IRR.
Then the chair reduces the whole meeting to one sentence: "We are not buying an $8 million business. We are betting on our ability to build a $20 million business."
That is the number your valuation has to survive. The committee tests seven things: whether the business runs without the founder, whether growth is credible and achievable, whether systems support scale, whether the financials are defensible, whether revenue is durable or episodic, whether the capital structure is disciplined, and whether the founder is aligned with the future of the business. Nobody in the room discusses how long the founder worked or how much he sacrificed.
How to Choose (or Interpret) the Right Valuation Method
The right method depends on your specifics, not on what's most commonly cited in industry articles.
Consider:
- Industry and asset intensity: asset-heavy businesses lean toward cost-based methods; asset-light, recurring-revenue businesses lean toward income or market approaches
- Availability of comparable transactions: thin comp data weakens the market approach's reliability
- Growth trajectory and forecastability: the more predictable your cash flow, the stronger a DCF case becomes
- Founder dependency and institutional readiness: buyers discount unpredictable, founder-reliant businesses regardless of which method produces the base number
- Likely buyer type: strategic acquirers, private equity firms, and family offices each weigh synergies, platform value, and risk differently
This is why Exit Boston builds buyer-specific Investment Summaries rather than defaulting to one generic valuation model. Positioning the business against each qualified buyer's acquisition criteria is what lets a founder defend a number in the room where it is decided.
Frequently Asked Questions
How are mergers and acquisitions valued?
M&A valuation typically combines cost, market, and income approaches to triangulate a defensible price. The weighting depends on your industry and how much comparable data is available.
What is the most common valuation method used in M&A?
EBITDA multiples derived from market comparables are the most widely used shorthand. DCF tends to take over for growth-stage businesses with highly forecastable cash flow.
Why do buyers and sellers often disagree on valuation?
Buyers discount for risk, integration cost, and founder dependency. Sellers factor in growth potential and strategic value. That gap is normal. Negotiation and methodology are meant to close it.
What is EBITDA and why does it matter in valuation?
EBITDA normalizes earnings by removing interest, taxes, depreciation, and amortization, allowing apples-to-apples comparison across companies. Adjusted EBITDA also corrects for owner-specific expenses.
How can a business owner increase their company's valuation before a sale?
Give the investment committee a credible answer to what the business becomes: leadership beyond you, durable revenue, systems that scale, and defensible financials. That is what the room actually prices.
Do small and middle-market companies use the same valuation methods as public companies?
Yes, the same core methods apply. But data scarcity and founder dependency in private, middle-market businesses require more judgment and adjustment than a straightforward public-company comp set allows.
